5-((Naphthalen-2-yloxy)methyl)-N-(2-(4-(pyridin-4-yl)thiazol-2-yl)ethyl)furan-2-carboxamide

Catalog No. :
ACTORW863
CAS No. :
1384642-72-1
Molecular Formula :
C26H21N3O3S
Molecular Weight :
455.54

IUPAC Name:5-((naphthalen-2-yloxy)methyl)-N-(2-(4-(pyridin-4-yl)thiazol-2-yl)ethyl)furan-2-carboxamide

5-((Naphthalen-2-yloxy)methyl)-N-(2-(4-(pyridin-4-yl)thiazol-2-yl)ethyl)furan-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((Naphthalen-2-yloxy)methyl)-N-(2-(4-(pyridin-4-yl)thiazol-2-yl)ethyl)furan-2-carboxamide
IUPAC Name5-((naphthalen-2-yloxy)methyl)-N-(2-(4-(pyridin-4-yl)thiazol-2-yl)ethyl)furan-2-carboxamide
Molecular FormulaC26H21N3O3S
Molecular Weight455.54
SMILESO=C(C1=CC=C(COC2=CC=C3C=CC=CC3=C2)O1)NCCC4=NC(C5=CC=NC=C5)=CS4
InChI KeyUUXDRWOWTUQDFX-UHFFFAOYSA-N
Synonym2-Furancarboxamide, 5-[(2-naphthalenyloxy)methyl]-N-[2-[4-(4-pyridinyl)-2-thiazolyl]ethyl]-
CAS No.1384642-72-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTORW863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTORW863 route product structure diagram
    ACTORW8631384642-72-1
Inquiry

2. ACTORW863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTORW863 route product structure diagram
    ACTORW8631384642-72-1
Inquiry

Comments (0)